SOX17 and pulmonary arterial hypertension: There were proteins and genes that were significantly affected both by the SOX17-signal 1 and signal 2 patient genotypes and by the loss of SOX17 expression via siRNA or CRISPRi in hPAEC, suggesting circulating proteins might reflect SOX17 dysfunction in PAH.